Physician profile
Gordon B Clark
NPI 1417937145
$4,507.30
in general payments reported to CMS, 2019-2025
23 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Obesity Medicine (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $97.38).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,267 · 2020: $211 · 2021: $124 · 2022: $587 · 2023: $2,135 · 2024: $67.14 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,564 · Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,564.06 |
| Food and Beverage | $753.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,960.46 | 2023 | Myfembree |
| Lupin INC. | $912.32 | 2019 | |
| Amgen INC. | $322.04 | 2019-2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $215.06 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.60 | 2022 | |
| Amarin Pharma, INC. | $136.99 | 2019-2022 | |
| Lundbeck LLC | $131.28 | 2022 | |
| Lilly USA, LLC | $125.58 | 2019-2024 | Olumiant, Taltz, Zepbound |
| Abbvie INC. | $106.36 | 2019-2022 | |
| Janssen Biotech, INC. | $84.92 | 2023-2025 | Tremfya |
| Esperion Therapeutics, INC. | $61.34 | 2024-2025 | Nexletol |
| Allergan, INC. | $55.60 | 2019 | |
| Pfizer INC. | $43.16 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.34 | 2019-2021 | |
| Indivior INC. | $38.15 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $21.63 | 2020 | |
| Galderma Laboratories, L.P. | $19.51 | 2019 | |
| Incyte Corporation | $19.37 | 2021 | |
| Supernus Pharmaceuticals, INC. | $17.36 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.97 | 2024 | |
| Exact Sciences Corporation | $14.26 | 2025 | Cologuard Collection Kit |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.